Skip to main content

Navigation group

Type at least 3 characters
707 articles

Articles

Original Research

Published on 04 Aug 2023

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients

in Gastrointestinal Cancers: Colorectal Cancer

  • Michal Mego
  • Radoslav Danis
  • Jozef Chovanec
  • Silvia Jurisova
  • Branislav Bystricky
  • Stefan Porsok
  • Peter Konkolovsky
  • Vladimir Vaclav
  • Maria Wagnerova
  • Marian Streško
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients
Frontiers in Oncology
doi 10.3389/fonc.2023.1168654
  • 2,779 views
  • 4 citations